|
AU2016269506A1
|
|
Virus like particle purification
|
|
CN102791286A
|
|
Targeted heterologous antigen presentation on calicivirus virus-like particles
|
|
WO2011090712A2
|
|
Methods for stabilizing influenza antigen enveloped virus-based virus-like particle solutions
|
|
CN102753582A
|
|
Chimeric rsv-f polypeptide and lentivirus or alpha-retrovirus gag-based vlps
|
|
US2010266636A1
|
|
Method of conferring a protective immune response to norovirus
|
|
CA2742295A1
|
|
Improved methods for isolating enveloped virus-based vlps free of infectious agents
|
|
KR20100083150A
|
|
Method of conferring a protective immune response to norovirus
|
|
AU2008224877A1
|
|
Virus like particle purification
|
|
EP2066354A1
|
|
Norovirus vaccine formulations
|
|
AU2007345768A1
|
|
Chimeric influenza virus-like particles
|
|
US2010047266A1
|
|
Chimeric virus-like particles
|
|
WO2006083322A2
|
|
Methods for the treatment and prevention of infection using anti-selectin agents
|
|
EP1735338A2
|
|
Anthrax antigens and methods of use
|
|
AU2001297913A1
|
|
Polyvalent nanoparticles
|
|
WO0052211A1
|
|
Vascular and mucosal shear analysis system for host-pathogen interactions
|
|
AU3372200A
|
|
Antibodies against hydrophobic proteins that are protective against candidiasis
|
